Understanding Cell Signals for Better Medicines
The role of dynamics in GPCR and arrestin allostery
This research aims to understand how key cell signals, called GPCRs, work in our bodies to help develop better medicines for conditions like cancer and heart disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11083764 on NIH RePORTER |
What this research studies
Our bodies rely on special proteins called GPCRs, which are like tiny switches on our cells that respond to signals from outside. Many common medicines, for conditions ranging from cancer to heart problems, work by targeting these GPCRs. This project wants to learn more about how these switches turn on and off, and how they send different messages inside the cell. By understanding these complex signals better, we hope to create more effective and precise treatments.
Who could benefit from this research
Good fit: Future patients with conditions such as cancer, heart disease, or inflammatory disorders could potentially benefit from the improved drug therapies that might arise from this fundamental understanding.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this foundational research, as it focuses on basic biological mechanisms rather than direct patient care.
Why it matters
Potential benefit: If successful, this work could lead to the development of new and more targeted medications for a wide range of diseases, including various cancers, cardiovascular issues, and inflammatory conditions.
How similar studies have performed: While many structures of GPCRs have been discovered, the detailed molecular mechanisms of their complex signaling are still not fully understood, making this a novel area of investigation.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Ziarek, Joshua James — Northwestern University
- Study coordinator: Ziarek, Joshua James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.